Editas Medicine, Inc. - EDIT

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)

Website: No information yet · Social: No information yet

Company profile

Latest / Compare

Q1 2026 · Q4 2025

Value (USD)

Total reported value ($000)

$148.7M

QoQ value delta ($000)

+$42.08M (+39.46%)

Implied price effect (QoQ)

+16.88%

Total shares

62,064,738

QoQ shares delta

+10,050,615 (+19.32%)

Total shares held by funds (by quarter)

Interactive chart by TradingView.

Top 25 only Full list

Partial Q1 2026 data: 209 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.

Manager	Value ($000)	Shares	% of 13F
BlackRock, Inc.	22,880	9,263,312	0.0%
VANGUARD GROUP INC	16,826	8,208,068	0.0%
VANGUARD CAPITAL MANAGEMENT LLC	10,384	4,204,369	0.0%
RENAISSANCE TECHNOLOGIES LLC	9,811	3,972,160	0.02%
VANGUARD PORTFOLIO MANAGEMENT LLC	7,776	3,148,570	0.0%
GEODE CAPITAL MANAGEMENT, LLC	5,711	2,311,789	0.0%
STATE STREET CORP	5,128	2,076,122	0.0%
Nuveen, LLC	4,884	1,977,509	0.0%
D. E. Shaw & Co., Inc.	4,801	1,943,893	0.0%
Opaleye Management Inc.	4,759	1,926,997	0.63%
JPMORGAN CHASE & CO	4,342	1,947,384	0.0%
TWO SIGMA INVESTMENTS, LP	3,826	1,549,063	0.0%
ACADIAN ASSET MANAGEMENT LLC	3,596	1,457,715	0.01%
AQR CAPITAL MANAGEMENT LLC	3,385	1,370,497	0.0%
RAYMOND JAMES FINANCIAL INC	3,195	1,293,848	0.0%
KENNEDY CAPITAL MANAGEMENT LLC	2,599	1,052,457	0.06%
TWO SIGMA ADVISERS, LP	2,509	1,224,100	0.0%
CITADEL ADVISORS LLC	2,163	875,789	0.0%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	2,127	861,326	0.0%
NORTHERN TRUST CORP	1,833	742,443	0.0%
MACKENZIE FINANCIAL CORP	1,803	730,054	0.0%
VANGUARD FIDUCIARY TRUST CO	1,516	614,036	0.0%
JACOBS LEVY EQUITY MANAGEMENT, INC	1,438	582,309	0.01%
GOLDMAN SACHS GROUP INC	1,379	558,577	0.0%
GSA CAPITAL PARTNERS LLP	1,073	434,413	0.07%